NCT06293482View on ClinicalTrials.gov

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2028

Conditions
Hearing Loss, SensorineuralHearing Loss, Bilateral
Interventions
DEVICE

Cochlear™ Nucleus® System

The Cochlear™ Nucleus ® System is a commercially available system intended for restoration of hearing sensation through electrical stimulation of the auditory nerve in adult patients with bilateral symmetrical sensorineural hearing loss.

Trial Locations (9)

10016

New York University, New York

19104

University of Pennsylvania Hospitals, Philadelphia

33146

University of Miami, Coral Gables

44195

Cleveland Clinic, Cleveland

46202

Indiana University, Indianapolis

64111

Midwest Ear Institute, Kansas City

85013

Barrow Neurological Institute, Phoenix

85718

Centre for Neurosciences, Tucson

90404

Pacific Neuroscience Institute, Santa Monica

Sponsors

Lead Sponsor

Cochlear
All Listed Sponsors
collaborator

NAMSA

OTHER

collaborator

LWB Consulting

UNKNOWN

collaborator

Althea Anagnostopoulos Harrington

UNKNOWN

collaborator

MV Clinical Research, LLC

UNKNOWN

lead

Cochlear

INDUSTRY

NCT06293482 - Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population | Biotech Hunter | Biotech Hunter